Stock-based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Summary Of Stock-Based Compensation Expense

The Company recognized stock-based compensation expense on all awards in the following categories in the consolidated statement of operations and comprehensive loss for the three months ended March 31, 2022 and 2021 (in thousands):

	Three Months Ended March 31,
	2022		2021
Cost of revenue	$	71	$	16
Operations and technology		1,446		226
General and administrative		3,604		636
Total stock-based compensation expense	$	5,121	$	878

Summary Of The Status Of The Stock Options

A summary of the status of the stock options as of March 31, 2022, and changes during the three months then ended is presented below (in thousands except share and per share amounts):

	Number of Shares			Weighted Average Exercise Price		Remaining Contractual Term (In Years)		Aggregate Intrinsic Value
Balance at December 31, 2021		8,843,297			4.12		6.75	$	16,632
Options granted		—
Options exercised		(60,757	)		1.94
Options cancelled		(255,346	)		6.49
Balance at March 31, 2022		8,527,194			4.07		6.45	$	11,464
Options exercisable as of March 31, 2022		5,631,646			2.53
Vested and expected to vest—March 31, 2022		8,527,194		$	4.07

Summary of Restricted Stock Units

The following table summarizes information pertaining to RSUs during the three months ended March 31, 2022 (in thousands, except for weighted-average grant-date fair value):

	Number of RSUs			Weighted-Average Grant Date Fair Value per Share
Nonvested at December 31, 2021		5,184,830		$	5.57
Granted		7,875,010		3.19
Vested		(645,719	)		4.26
Cancelled/forfeited		(25,310	)		10.11
Nonvested at March 31, 2022		12,388,811		$	4.12